H19 also emerged as a promising predictor of event-free survival in patients with IPAH and was proposed as a potential therapeutic target of maladaptive right ventricular remodeling, as supported by the additional in vivo knock-down findings.67 Here, H19 is linked to idiopathic pulmonary arterial hypertension.